May 23, 2017
Biocartis launches colorectal cancer test
Biocartis Group, an innovative molecular diagnostics company, has launched of the Idylla NRAS Mutation Test.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: NRAS Mutation Test.